One blog examines GAVI Alliance's efforts to accelerate introduction of hepatitis B vaccines in developing countries

"I am looking forward to participating in the 2012 World Cancer Leaders' Summit, to be held in Montreal, Canada on August 27," GAVI Alliance Deputy CEO Helen Evans writes in this post in the One Blog. "This will be an opportunity to take stock of where the world is with regards to cancer prevention and treatment and to learn more about action to address the existing challenges to eliminating cancer as a life-threatening disease for future generations," she writes, and discusses GAVI's efforts to "accelerat[e] the introduction of hepatitis B vaccines in developing countries since 2000," noting "GAVI has helped prevent an estimated 3.7 million deaths from liver cancer (caused by hepatitis B)" (8/21).